CTKB Historical PE Ratio image   This CTKB PE ratio history page last updated 7/4/2024
CTKB Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2024
5/8/2024
6.27-0.05-0.20NA
Q4 2023
2/28/2024
8.740.040.1654.6
Q3 2023
11/7/2023
4.45-0.05-0.20NA
Q2 2023
8/8/2023
8.92-0.03-0.12NA
Q1 2023
5/9/2023
11.670.000.00NA
Q4 2022
2/28/2023
10.300.060.2442.9
Q3 2022
11/9/2022
13.700.040.1685.6
Q2 2022
8/10/2022
15.450.030.12128.8
Q1 2022
5/11/2022
7.410.010.04185.2
Q4 2021
2/23/2022
13.120.040.1682.0
Q3 2021
11/8/2021
25.040.020.08313.0
Q2 2021
9/2/2021
24.390.000.00NA
CTKB PE History Chart
PeriodPriceGAAPTTMPE
Q1 2024
5/8/2024
6.27-0.05-0.09NA
Q4 2023
2/28/2024
8.740.04-0.04NA
Q3 2023
11/7/2023
4.45-0.05-0.02NA
Q2 2023
8/8/2023
8.92-0.030.07127.4
Q1 2023
5/9/2023
11.670.000.10116.7
Q4 2022
2/28/2023
10.300.060.1379.2
Q3 2022
11/9/2022
13.700.040.08171.2
Q2 2022
8/10/2022
15.450.030.10154.5
Q1 2022
5/11/2022
7.410.010.07105.9
Q4 2021
2/23/2022
13.120.04NANA
Q3 2021
11/8/2021
25.040.02NANA
Q2 2021
9/2/2021
24.390.00NANA
Quotes delayed 20 minutes

Email EnvelopeFree CTKB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cytek Biosciences (CTKB) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CTLT PE Ratio History
CTMX PE Ratio History
CTNM PE Ratio History
CTSO PE Ratio History
CTXR PE Ratio History
CUE PE Ratio History
CUTR PE Ratio History
CVRX PE Ratio History
CVS PE Ratio History
CWBR PE Ratio History
How should the CTKB historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Cytek Biosciences. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CTKB Historical PE Ratio page.

What is the average historical PE for CTKB based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CTKB historical PE ratio using the annualized quarterly earnings method works out to 127.4.

What is the average historical PE for CTKB based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CTKB historical PE ratio using the TTM earnings method works out to 125.8.

On this page we presented the CTKB Historical PE Ratio information for Cytek Biosciences' stock. The average CTKB historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 127.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CTKB historical PE based on this TTM earnings result method is 125.8. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CTKB historical PE result, against the recent PE: when this page was posted on 7/3/2024, the most recent closing price for CTKB had been 5.57, and the most recent quarterly earnings result, annualized, was 0.16. Meanwhile, the most recent TTM earnings summed to 0.07. From these numbers, we calculate the recent CTKB PE on 7/3/2024 based on annualized quarterly EPS was 34.8. Based on CTKB's history, that recent PE is low relative to the historical average, with the recent PE 72.7% lower than the historical average PE across our data set for Cytek Biosciences. Looking at the recent CTKB PE on 7/3/2024 based on TTM EPS, we calculate the ratio at 79.6. Based on CTKB's history, that recent PE is low relative to the historical average, with the recent PE 36.7% lower than the average PE across our Cytek Biosciences data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on CTKB or any other given stock, valuation analysis for CTKB can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cytek Biosciences PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CTKB. Thanks for visiting, and the next time you need to research CTKB Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding VRAI, WH Next Dividend Date, Top Ten Hedge Funds Holding BSJV.

 

CTKB Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.